DISCOVERY CHEMISTRY SERVICES

Apeloa offers a full range of discovery support services, including a specialization in Medicinal Chemistry or Med-chem services. With Medicinal Chemistry centers of excellence in our three R&D facilities located in Boston (USA), Hengdian (China) and Shanghai (China), Apeloa has a proven ability to advance early-stage discovery and development of new molecules into manufacturable Starting Materials, Intermediates, and Active Pharmaceutical Ingredients (APIs).

MEDICINAL CHEMISTRY

Apeloa CRO’s Med-Chem capabilities cover a full range of discovery support services, starting with target validation, hit screening, hit-to-lead, and lead optimization. Using the latest tools and analysis technologies, Apeloa CRO’s Med-Chem services improve potency, selectivity, physico-chemical and ADME properties through optimizing and fine-tuning the compound of choice. We also support new therapeutic approaches such as TPD/PROTACs with Apeloa’s innovative platform and integrated CRO work.

Large room filled with modern white Agilent HPLC instruments used to support medchem and discovery services at Apeloa.

FULL RANGE OF DISCOVERY CHEMISTRY SERVICES

Our Med-Chem service offering covers the entire spectrum of critical discovery services needed to develop optimized molecules quickly and efficiently for specific medicinal applications. Some of our key Med-chem services and activities include:

  • Hit to lead
  • Library screening
  • Lead Generation
  • Lead Optimization
  • Building Block (BB) Library
  • Intermediate collection
  • Absorption, distribution, metabolism, and excretion(ADME)
  • Pharmacophore Identification
  • Scale-Up
Five story modern R&D building located on pharmaceutical services campus in Pudong, Shanghai location China.

THREE MODERN R&D SITES

Apleoa CDMO has established three modern R&D facilities designed to deliver world-class discovery support services. Apeloa CRO’s Boston (USA) R&D facility, launching in 2023, together with our Shanghai and Hengdian teams, will handle the full range of chemistry services from the earliest stages of med-chem modification to potential GMP scale-up of the molecule.

White robotic autosampler arm shown picking up capped glass sample vials for analytical GC instrument.

COMPOUND DESIGN AND SYNTHESIS SERVICES

Our goal is to efficiently develop highly bio-active molecules. Our Med-chem scientists can perform parallel/matrix library design and synthesis for hit identification and validation. Lead candidates are prioritized and optimized through analysis of key interactions, model pharmacophores, binding predictions and ADME/tox properties. Fully supported by analytical services, we utilize cutting edge tools like Mass-spectrometer-based services to detect and quantify the active ingredient and its metabolites/biomarkers to support pharmacokinetic studies.

White R&D laboratory with scientist in white lab coat using silver lab instrument for R&D new modalities.

ADME/Analytical

Apeloa’s team has a wide range of state-of-the-art analytical instruments to provide a full spectrum of services. Please see our analytical page for more details on available instruments. We are building expanded SFC separation capability at our Shanghai R&D center and our ADME service is currently supported by our Hengdian China R&D center.

Scientist in white lab coat and blue glove using controls on stainless steel control panel in CRO R&D laboratory.

TECH-PACKAGE TRANSFER ADVANTAGE

When a customer begins the project with us at an early discovery stage, we will have key intermediates, marked impurity and technical know-how applied. This will greatly accelerate the tech-package transfer process to late development and manufacturing stages, which will save significant cost and time for the benefit of our customer. Apeloa is a leader in manufacturing in China and have the capability of offering a one-stop chemistry service, it’s beneficial for customers to being the project with our discovery chemistry service and then seamlessly tech transfer to scaled manufacturing.